Digital Content 
NEWS #PharmaBuzz
13 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-to-unveil-the-multi-tumor-potential-of-atnm-400-a-first-in-class-actinium-225-radiotherapy-with-data-in-non-small-cell-lung-cancer-at-the-aacr-nci-eortc-international-conference-on-molecular-targets-and--302582225.html
09 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/09/3163854/0/en/Ariceum-Therapeutics-Data-at-the-2025-European-Association-of-Nuclear-Medicine-Annual-Congress-Further-Supports-the-Advancement-of-225Ac-SSO110-for-Extensive-Stage-Small-Cell-Lung-.html
11 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/11/3148516/29076/en/Cellectar-Biosciences-and-ITM-Enter-Supply-Agreement-for-GMP-Grade-Actinium-225.html
29 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250429877323/en/Bayer-Initiates-Phase-I-Study-Targeting-GPC3-With-Actinium-225-Radiopharmaceutical-in-Patients-With-Advanced-Hepatocellular-Carcinoma
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067172/0/en/ITM-and-Alpha-9-Oncology-Enter-Into-Supply-Agreement-for-Therapeutic-Medical-Radioisotope-Actinium-225.html
27 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-announces-atnm-400-a-novel-non-psma-targeting-first-in-class-prostate-cancer-radiotherapy-leveraging-actinium-225-302412945.html
Share 